Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill (2016 - 2026)

Amphastar Pharmaceuticals has reported Goodwill over the past 13 years, most recently at $3.4 million for Q4 2025.

  • For Q4 2025, Goodwill rose 11.58% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $3.4 million, up 11.58%, while the annual FY2025 figure was $3.4 million, 11.58% up from the prior year.
  • Goodwill for Q4 2025 was $3.4 million at Amphastar Pharmaceuticals, roughly flat from $3.4 million in the prior quarter.
  • Over five years, Goodwill peaked at $3.8 million in Q2 2021 and troughed at $2.9 million in Q3 2022.
  • A 5-year average of $3.3 million and a median of $3.2 million in 2023 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: decreased 20.47% in 2022 and later increased 11.58% in 2025.
  • Year by year, Goodwill stood at $3.3 million in 2021, then decreased by 5.64% to $3.1 million in 2022, then increased by 2.88% to $3.2 million in 2023, then dropped by 5.19% to $3.0 million in 2024, then rose by 11.58% to $3.4 million in 2025.
  • Business Quant data shows Goodwill for AMPH at $3.4 million in Q4 2025, $3.4 million in Q3 2025, and $3.4 million in Q2 2025.